SCHEMBL94963

SCHEMBL94963

CCCCCC(=O)OC(C)OOC(C)(C)CCC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.51
MAPT P10636 3/20 0.45
MAPK1 P28482 3/20 0.45
ALDH1A1 P00352 1/20 0.43
PRKCA P17252 1/20 0.40
PRKCE Q02156 1/20 0.40
PRKCQ Q04759 1/20 0.40
PRKCD Q05655 1/20 0.40
DGKA P23743 1/20 0.39
CYP1A2 P05177 3/20 0.38
MEN1 O00255 1/20 0.38
GMNN O75496 1/20 0.38
HSP90AA1 P07900 1/20 0.38
BLM P54132 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
NR1H4 Q96RI1 1/20 0.38
TP53 P04637 1/20 0.38
CYP2C9 P11712 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL187385 0.89 LMNA (0.53) LMNAMAPTMAPK1ALDH1A1PRKCA
SCHEMBL4268444 0.87 LMNA (0.50) LMNAMAPTMAPK1ALDH1A1PRKCA
SCHEMBL94108 0.86 LMNA (0.56) LMNAMAPTMAPK1ALDH1A1PRKCA
SCHEMBL7208042 0.85 LMNA (0.49) LMNAMAPTMAPK1ALDH1A1PRKCA
SCHEMBL2829468 0.83 LMNA (0.53) LMNAMAPTMAPK1ALDH1A1PRKCA
SCHEMBL27968565 0.81 LMNA (0.49) LMNAMAPTMAPK1ALDH1A1PRKCA
SCHEMBL6690274 0.79 LMNA (0.49) LMNAMAPTMAPK1ALDH1A1PRKCA
SCHEMBL20956955 0.78 LMNA (0.47) LMNAMAPTMAPK1ALDH1A1PRKCA
SCHEMBL38656927 0.78 LMNA (0.41) LMNAMAPTMAPK1ALDH1A1PRKCA
SCHEMBL29164108 0.78 LMNA (0.38) LMNAMAPTMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 257 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-5032733-A None JP disclosed
EP-4258342-B1 TWO-COMPONENT CURABLE COMPOSITION AND CURED PRODUCT THEREOF COSMO OIL LUBRICANTS CO LTD (JP) 2026-04-01 EP disclosed
US-12503621-B2 Coating composition and method for forming multilayer coating film KANSAI PAINT CO., LTD. (JP) 2025-12-23 US disclosed
EP-4578884-A2 RESIN COMPOSITION, PREPREG, AND FIBER-REINFORCED PLASTIC Mitsubishi Chemical Corporation (JP) 2025-07-02 EP disclosed
US-12296040-B2 Cosmetic oil thickener and oil-soluble copolymer SHISEIDO COMPANY, LTD. (JP) 2025-05-13 US disclosed
US-20250046626-A1 SEMICONDUCTOR DEVICE MANUFACTURING METHOD RESONAC CORPORATION (JP) 2025-02-06 US disclosed
US-20250026928-A1 CROSSLINKABLE RESIN COMPOSITION, CURED PRODUCT, LAMINATE AND HEAT-RESISTANT MEMBER DIC CORPORATION (JP) 2025-01-23 US disclosed
US-20240417549-A1 Crosslinked Rubber Composition and Method for Producing Crosslinked Rubber Composition JAPAN ELASTOMER CO., LTD. (JP) 2024-12-19 US disclosed
US-12165882-B2 Semiconductor device manufacturing method RESONAC CORPORATION (JP) 2024-12-10 US disclosed
EP-3521907-B1 PHOTOCHROMIC LENS AND POLYMERIZABLE COMPOSITION MITSUI CHEMICALS INC (JP) 2024-12-04 EP disclosed
EP-1542273-A1 Circuit-connecting material and circuit terminal connected structure and connecting method Hitachi Chemical Co., Ltd. (JP) 2005-06-15 EP disclosed
US-20040222408-A1 SUPERIOR LOW-TEMPERATURE RAPID CURABILITY AND ALSO HAVING A LONG POT LIFE HITACHI CHEMICAL COMPANY, LTD. (JP) 2004-11-11 US disclosed
US-6777464-B1 ELECTRONIC CIRCUIT-CONNECTING MATERIAL HAVING A SUPERIOR LOW-TEMPERATURE RAPID CURABILITY AND ALSO HAVING A LONG POT LIFE HITACHI CHEMICAL COMPANY, LTD. (JP) 2004-08-17 US disclosed
US-20040024152-A1 Gas hydrate formation inhibitor and method for inhibiting gas hydrate formation with the same MITSUBISHI RAYON CO., LTD. (JP) 2004-02-05 US disclosed
US-20030106462-A1 Pigment and/or dye enveloped in a polymer, water, and at least one of acetylene alcohol/glycol surfactants, glycol ethers, or 1,2-alkylene glycols; dispersion stability, ejection stability, colorfastness, storage stability SEIKO EPSON CORPORATION (JP) 2003-06-12 US disclosed
US-6562513-B1 Thermopolymerizable composition for battery use SHOWA DENKI KABUSHIKI KAISHA (JP) 2003-05-13 US disclosed
EP-1295916-A1 INK-JET RECORDING INK, INK-JET RECORDING INK SET, RECORDING METHOD, PRINT, AND INK-JET RECORDING APPARATUS SEIKO EPSON CORPORATION (JP) 2003-03-26 EP disclosed
EP-1277402-A1 ADDITIVE FOR BORDEAUX MIXTURE AND BORDEAUX MIXTURE NOF CORPORATION (JP) 2003-01-22 EP disclosed
EP-0979854-A1 CIRCUIT CONNECTING MATERIAL, AND STRUCTURE AND METHOD OF CONNECTING CIRCUIT TERMINAL HITACHI CHEMICAL COMPANY, LTD. (JP) 2000-02-16 EP disclosed
JP-H0532733-A PRODUCTION OF VARNISH FOR PAINT NIPPON OIL & FATS CO LTD 1993-02-09 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12296040-B2 Cosmetic oil thickener and oil-soluble copolymer PCNA, FASN, CUTA LMNA 3107/4885MAPT 463/4885MAPK1 585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.